Mirvetuximab
- CAS No.
- 1453084-36-0
- Chemical Name:
- Mirvetuximab
- Synonyms
- M9346A;Mirvetuximab;>95% by SDS-PAGE;Mirvetuximab (DHD10402);Mirvetuximab (anti-FOLR1);Research Grade Mirvetuximab;Research Grade Mirvetuximab(DHD10402)
- CBNumber:
- CB88080969
- Molecular Formula:
- Molecular Weight:
- 0
- MDL Number:
- MOL File:
- Mol file
- MSDS File:
- SDS
| Product description | Number | Pack Size | Price |
| Mirvetuximab | CLA1417 | 1mg | $962.5 |
| Mirvetuximab | CLA1417 | 2mg | $1375 |
| Mirvetuximab | CLA1417 | 5mg | $2200 |
| Mirvetuximab | CLA1417 | 10mg | $3300 |
| Mirvetuximab 99.88% | CS-0612863 | 1mg | $422 |
| form | Liquid |
|---|---|
| color | Colorless to light yellow |
| FDA UNII | 4MFH3B1EFU |
Mirvetuximab price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Biosynth | CLA1417 | Mirvetuximab | 1453084-36-0 | 1mg | $962.5 | 2026-06-04 | Buy |
| Biosynth | CLA1417 | Mirvetuximab | 1453084-36-0 | 2mg | $1375 | 2026-06-04 | Buy |
| Biosynth | CLA1417 | Mirvetuximab | 1453084-36-0 | 5mg | $2200 | 2026-06-04 | Buy |
| Biosynth | CLA1417 | Mirvetuximab | 1453084-36-0 | 10mg | $3300 | 2026-06-04 | Buy |
| ChemScene | CS-0612863 | Mirvetuximab 99.88% | 1453084-36-0 | 1mg | $422 | 2026-06-04 | Buy |
Mirvetuximab Chemical Properties,Uses,Production
Uses
Mirvetuximab (M9346A) is an anti-FOLR1 (folate receptor 1) monoclonal antibody. Mirvetuximab is the antibody moiety of folate receptor alpha (FRα)-targeting ADC (Mirvetuximab soravtansine). Mirvetuximab soravtansine can be used in ovarian and other FRα-positive cancer research[1][2][3].
References
[1] Moore KN, et al. Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study. J Clin Oncol. 2017 Apr 1;35(10):1112-1118. DOI:10.1200/JCO.2016.69.9538
[2] Loebrich S, et al. Development and Characterization of a Neutralizing Anti-idiotype Antibody Against Mirvetuximab for Analysis of Clinical Samples. AAPS J. 2017 Jul;19(4):1223-1234. DOI:10.1208/s12248-017-0098-0
[3] Ab O, et al. IMGN853, a Folate Receptor-α (FRα)-Targeting Antibody-Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FRα-Expressing Tumors. Mol Cancer Ther. 2015 Jul;14(7):1605-13. DOI:10.1158/1535-7163.MCT-14-1095
Mirvetuximab Preparation Products And Raw materials
Raw materials
Preparation Products
Mirvetuximab Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| BOC Sciences | +1-631-485-4226 | inquiry@bocsci.com | United States | 19936 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354; +17819995354 | marketing@targetmol.com | United States | 32466 | 58 |
| Aladdin Scientific | tp@aladdinsci.com | United States | 57505 | 58 | |
| Shanghai YuanYe Biotechnology Co., Ltd. | 13636370518 | shyysw007@163.com | China | 89686 | 60 |
| ShangHai Biochempartner Co.,Ltd | 177-54423994 17754423994 | 2853530910@QQ.com | China | 8000 | 62 |
| Wuhan Chemstan Biotechnology Co., Ltd. | 027-65317797 15926423062 | 422450190@qq.com | China | 10308 | 58 |
| TargetMol Chemicals Inc. | 4008200310 15002144251 | marketing@tsbiochem.com | China | 24959 | 58 |
| Biolab Reagents | 027-65279366 18108604356 | products@biolabreagent.com | China | 9865 | 58 |
| Wuhan Jingkangen Biomedical Technology Co., Ltd | 13720134139 086-15871494362 13720134139 | orders@jknbiochem.com | China | 7239 | 58 |
| Shanghai Yifei Biotechnology Co. , Ltd. | 021-65675885 18964387627 | customer_service@efebio.com | China | 11972 | 58 |
View Lastest Price from Mirvetuximab manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2026-07-03 | Mirvetuximab
1453084-36-0
|
$322.00-1280.00 | > 95% | 10g | TargetMol Chemicals Inc. |
-
- Mirvetuximab
1453084-36-0
- $322.00-1280.00
- > 95%
- TargetMol Chemicals Inc.
